-
Written by The Hormona Team
Every menstrual cycle relies on a complex chain of signals, and follicle-stimulating hormone plays a central role in preparing your body for ovulation. When you receive a lab result showing your numbers, it can feel confusing or stressful to interpret what those values mean for your fertility or menopausal transition. Understanding your baseline data helps you take proactive steps in your health care. This chart breaks down the numbers by age and cycle phase, so you can confidently discuss your results with a healthcare provider.
- Your pituitary gland produces follicle-stimulating hormone to signal your ovaries to mature an egg each month.
- A normal range shifts across different life stages and varies depending on the timing of your menstrual cycle.
- Doctors typically recommend day 2-5 testing to get a picture of your ovarian reserve.
- The symptoms aren’t caused by high hormone levels themselves, but rather by the sudden drop in estrogen that happens as follicle-stimulating hormone rises
FSH production and function
Your reproductive system operates on a constant feedback loop between your brain and your ovaries. The process starts in your brain, where the pituitary gland produces follicle-stimulating hormone (FSH). As the name suggests, this hormone travels to your ovaries and signals them to grow and mature an egg for ovulation.
Once those ovarian follicles start growing, they release estrogen into your bloodstream. Your brain monitors this rising estrogen and eventually realizes the ovaries are doing their job, so it slows down the production of FSH. If your ovaries struggle to respond and don’t produce enough estrogen, your brain pumps out even more FSH to try and force the issue. That means a higher number on a lab test often indicates that the ovaries are working much harder to mature an egg.
Normal FSH ranges by age
Your numbers don’t stay static throughout the month. During the follicular phase at the beginning of your cycle, levels slowly rise to stimulate egg growth. Right before ovulation, you may experience a brief but sharp ovulatory peak, however in some cycles this spike doesn’t happen. This peak drops off quickly as you enter the luteal phase for the second half of your cycle.
Looking at a single lab result without context can easily cause anxiety. The table below outlines a standard normal range based on different life stages. Keep in mind that your personal baseline might look slightly different, and your healthcare provider will interpret these numbers alongside your symptoms and cycle history. Values are measured in mIU/mL, which stands for milli-international units per milliliter [1].
| Life stage | Normal range (mIU/mL) |
|---|---|
| Follicular phase | 1.37 to 9.9 |
| Ovulatory peak | 6.17 to 17.2 |
| Luteal phase | 1.09 to 9.2 |
| Postmenopause | 19.3 to 100.6 |
Medscape. Follicle Stimulating Hormone. Reference Range. 2025
While this data is not perfectly representative of all women, you can see the average day 3 FSH levels for the normal range group, defined as under 13.03 IU/L, broken down by age in women who underwent IVF [2].
| Age | Average values (mIU/mL) |
|---|---|
| Under 35 | 6.5 ± 2.3 |
| 35-38 | 7.4 ± 2.4 |
| 38-40 | 7.8 ± 2.5 |
| Over 40 | 8.2 ± 2.4 |
Fertility and Sterility Vol. 87, No. 4, April 2007
In the group with average values above 13 IU/L, the numbers were:
| Age | Average values (mIU/mL) |
|---|---|
| Under 35 | 14.9 ± 2.1 |
| 35-38 | 15.4 ± 3.2 |
| 38-40 | 16.4 ± 3.9 |
| Over 40 | 16.1 ± 6.8 |
Fertility and Sterility Vol. 87, No. 4, April 2007
Symptoms linked to high FSH
It’s completely normal to feel concerned if a blood test returns a high result. But it helps to know that high FSH itself produces no physical sensation, so you can’t actually “feel” it. Instead, the symptoms you notice come directly from the accompanying significant changes in estrogen.
As your ovaries become less responsive over time, your estrogen levels naturally decline. Before that happens, though, there is a period of time when your hormones fluctuate dramatically, sometimes rising even higher than they did before. The estrogen spikes can trigger heavy periods and increased breast tenderness. The drop triggers physical changes like hot flashes, night sweats, dry skin and hair loss.
Polycystic ovary syndrome name change
While high numbers usually point to declining ovarian reserve, low or fluctuating numbers during reproductive years can sometimes indicate other patterns. For example, polycystic ovary syndrome, also recently renamed polyendocrine metabolic ovarian syndrome (PMOS), often involves a disrupted hormone feedback loop. The medical community updated the name to reflect a multisystem metabolic focus rather than just an ovarian one. This change highlights how insulin, androgens, and other factors influence your cycle and overall health [3].
Perimenopause and postmenopause results
As you enter your mid 40s, your body naturally begins the menopausal transition. During perimenopause, your numbers might fluctuate from month to month, so a single test rarely tells the whole story. However, levels consistently above 25 mIU/mL act as clinical markers that you have reached perimenopause [4].
Hormone tracking at home
A single blood test only offers a snapshot of your health on one specific day, so tracking your patterns over time gives you a much clearer picture. The Hormona Wellness Kit and Hormona Perimenopause Kit are at-home educational tests that help you understand your FSH, estrogen, and progesterone metabolites through simple urine samples.
By logging these results in the Hormona app alongside daily symptoms like your sleep quality and energy levels, you can map your personal hormone trends. This longitudinal data provides the rich context needed for better, more informed conversations with a healthcare provider.
Consultation with a healthcare provider
You know your body best, so trust your instincts if something feels off. Seek medical consultation if you experience sudden changes in your cycle length, unusually heavy bleeding, or severe hot flashes that disrupt your sleep. Always speak with a healthcare provider before starting any new supplements or making major lifestyle shifts. They can help you interpret your tracking data and build a care plan tailored to your specific biology.
Proactive hormonal health
Understanding your body’s natural rhythms is a powerful step toward lifelong health literacy. Gathering baseline data now helps you approach future transitions with confidence and clarity, supporting your overall wellbeing for years to come.
FAQs
What is the normal FSH level for age?
During your reproductive years, a normal range generally falls between 1.37 and 9.9 mIU/mL. During perimenopause, levels fluctuate month to month and can rise above 25.0 mIU/mL [4].
What does high FSH feel like?
High FSH does not actually cause physical sensations. What you feel are the symptoms of low estrogen, which often accompanies those high numbers. This includes hot flashes, night sweats, vaginal dryness, and irregular periods.
Is it better to have high or low FSH?
Neither is universally better, as normal levels depend entirely on your age and cycle phase. High levels in your twenties might suggest diminished ovarian reserve, while high levels in your fifties simply indicate a natural transition into menopause.
Is FSH a tumor marker?
No, it’s not a tumor marker. It’s a natural reproductive hormone produced by your pituitary gland to regulate your menstrual cycle and ovarian function.
What are 7 signs of perimenopause?
Seven common signs include irregular periods, hot flashes, night sweats, sleep disturbances, mood changes, vaginal dryness, and shifts in your energy levels. These occur as your estrogen levels naturally drop.
What FSH level confirms perimenopause?
Clinicians generally look for levels consistently above 25 mIU/mL, alongside emerging symptoms. During perimenopause, levels still fluctuate, so a single test can’t definitively confirm your status, making symptom tracking highly valuable.
-
Dr Singh is the Medical Director of the Indiana Sleep Center. His research and clinical practice focuses on the myriad of sleep.
- Sofronescu, A., Devaraj, S. (2025). Follicle-Stimulating Hormone (FSH). References Range. Available online: https://emedicine.medscape.com/article/2089048-overview#a1
- Luna, M., Grunfeld, L., Mukherjee, T., Sandler, B., & Copperman, A. B. (2007). Moderately elevated levels of basal follicle-stimulating hormone in young patients predict low ovarian response, but should not be used to disqualify patients from attempting in vitro fertilization. Fertility and sterility, 87(4), 782–787. https://doi.org/10.1016/j.fertnstert.2006.08.094
- Teede, H. J., Khomami, M. B., Morman, R., Laven, J. S. E., Joham, A. E., Costello, M. F., Patil, M., Rees, D. A., Berry, L., Cree, M. G., Zhao, H., Norman, R. J., Dokras, A., Piltonen, T., & Global Name Change Consortium (2026). Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet (London, England), 407(10545), 2329–2339. https://doi.org/10.1016/S0140-6736(26)00717-8
- Harlow, S. D., Gass, M., Hall, J. E., Lobo, R., Maki, P., Rebar, R. W., Sherman, S., Sluss, P. M., de Villiers, T. J., & STRAW 10 Collaborative Group (2012). Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause (New York, N.Y.), 19(4), 387–395. https://doi.org/10.1097/gme.0b013e31824d8f40
- Sofronescu, A., Devaraj, S. (2025). Follicle-Stimulating Hormone (FSH). References Range. Available online: https://emedicine.medscape.com/article/2089048-overview#a1
- Luna, M., Grunfeld, L., Mukherjee, T., Sandler, B., & Copperman, A. B. (2007). Moderately elevated levels of basal follicle-stimulating hormone in young patients predict low ovarian response, but should not be used to disqualify patients from attempting in vitro fertilization. Fertility and sterility, 87(4), 782–787. https://doi.org/10.1016/j.fertnstert.2006.08.094
- Teede, H. J., Khomami, M. B., Morman, R., Laven, J. S. E., Joham, A. E., Costello, M. F., Patil, M., Rees, D. A., Berry, L., Cree, M. G., Zhao, H., Norman, R. J., Dokras, A., Piltonen, T., & Global Name Change Consortium (2026). Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet (London, England), 407(10545), 2329–2339. https://doi.org/10.1016/S0140-6736(26)00717-8
- Harlow, S. D., Gass, M., Hall, J. E., Lobo, R., Maki, P., Rebar, R. W., Sherman, S., Sluss, P. M., de Villiers, T. J., & STRAW 10 Collaborative Group (2012). Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause (New York, N.Y.), 19(4), 387–395. https://doi.org/10.1097/gme.0b013e31824d8f40